AI assistant
Sending…
Lunai Bioworks Inc. — Director's Dealing 2021
Dec 29, 2021
34813_dirs_2021-12-28_1464526d-a2b2-4dde-8146-3c2e27475049.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Enochian Biosciences Inc (ENOB)
CIK: 0001527728
Period of Report: 2021-12-27
Reporting Person: Alton Gregg H (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-27 | Option to purchase shares of common stock | $7.93 | A | 9458 | Acquired | 2031-12-27 | Common stock (9458) | Direct |
More from Lunai Bioworks Inc.
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 1
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 13
Regulatory Filings
2026
Feb 23
Interim / Quarterly Report
2026
Feb 17
Regulatory Filings
2026
Feb 12